These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8387488

  • 1. Role of the fusion peptide sequence in initial stages of influenza hemagglutinin-induced cell fusion.
    Schoch C, Blumenthal R.
    J Biol Chem; 1993 May 05; 268(13):9267-74. PubMed ID: 8387488
    [Abstract] [Full Text] [Related]

  • 2. Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus.
    Gething MJ, Doms RW, York D, White J.
    J Cell Biol; 1986 Jan 05; 102(1):11-23. PubMed ID: 3753607
    [Abstract] [Full Text] [Related]

  • 3. Effects of exposure to low pH on the lateral mobility of influenza hemagglutinin expressed at the cell surface: correlation between mobility inhibition and inactivation.
    Gutman O, Danieli T, White JM, Henis YI.
    Biochemistry; 1993 Jan 12; 32(1):101-6. PubMed ID: 8418830
    [Abstract] [Full Text] [Related]

  • 4. The role of the cytoplasmic tail region of influenza virus hemagglutinin in formation and growth of fusion pores.
    Melikyan GB, Jin H, Lamb RA, Cohen FS.
    Virology; 1997 Aug 18; 235(1):118-28. PubMed ID: 9300043
    [Abstract] [Full Text] [Related]

  • 5. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
    Li M, Li ZN, Yao Q, Yang C, Steinhauer DA, Compans RW.
    J Virol; 2006 Jun 18; 80(12):6106-14. PubMed ID: 16731949
    [Abstract] [Full Text] [Related]

  • 6. Delay time for influenza virus hemagglutinin-induced membrane fusion depends on hemagglutinin surface density.
    Clague MJ, Schoch C, Blumenthal R.
    J Virol; 1991 May 18; 65(5):2402-7. PubMed ID: 1850019
    [Abstract] [Full Text] [Related]

  • 7. Intermonomer disulfide bonds impair the fusion activity of influenza virus hemagglutinin.
    Kemble GW, Bodian DL, Rosé J, Wilson IA, White JM.
    J Virol; 1992 Aug 18; 66(8):4940-50. PubMed ID: 1629960
    [Abstract] [Full Text] [Related]

  • 8. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers.
    Danieli T, Pelletier SL, Henis YI, White JM.
    J Cell Biol; 1996 May 18; 133(3):559-69. PubMed ID: 8636231
    [Abstract] [Full Text] [Related]

  • 9. Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectivity.
    Simpson DA, Lamb RA.
    J Virol; 1992 Feb 18; 66(2):790-803. PubMed ID: 1309913
    [Abstract] [Full Text] [Related]

  • 10. Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore.
    Kozerski C, Ponimaskin E, Schroth-Diez B, Schmidt MF, Herrmann A.
    J Virol; 2000 Aug 18; 74(16):7529-37. PubMed ID: 10906206
    [Abstract] [Full Text] [Related]

  • 11. Assessment of fusogenic properties of influenza virus hemagglutinin deacylated by site-directed mutagenesis and hydroxylamine treatment.
    Philipp HC, Schroth B, Veit M, Krumbiegel M, Herrmann A, Schmidt MF.
    Virology; 1995 Jun 20; 210(1):20-8. PubMed ID: 7793071
    [Abstract] [Full Text] [Related]

  • 12. Deacylation of the hemagglutinin of influenza A/Aichi/2/68 has no effect on membrane fusion properties.
    Steinhauer DA, Wharton SA, Wiley DC, Skehel JJ.
    Virology; 1991 Sep 20; 184(1):445-8. PubMed ID: 1871979
    [Abstract] [Full Text] [Related]

  • 13. The role of acidic residues in the "fusion segment" of influenza A virus hemagglutinin in low-pH-dependent membrane fusion.
    Nobusawa E, Hishida R, Murata M, Kawasaki K, Ohnishi S, Nakajima K.
    Arch Virol; 1995 Sep 20; 140(5):865-75. PubMed ID: 7605199
    [Abstract] [Full Text] [Related]

  • 14. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites.
    Brassard DL, Lamb RA.
    Virology; 1997 Sep 29; 236(2):234-48. PubMed ID: 9325231
    [Abstract] [Full Text] [Related]

  • 15. Heterologous transmembrane and cytoplasmic domains direct functional chimeric influenza virus hemagglutinins into the endocytic pathway.
    Roth MG, Doyle C, Sambrook J, Gething MJ.
    J Cell Biol; 1986 Apr 29; 102(4):1271-83. PubMed ID: 3007532
    [Abstract] [Full Text] [Related]

  • 16. Site-specific mutagenesis identifies three cysteine residues in the cytoplasmic tail as acylation sites of influenza virus hemagglutinin.
    Veit M, Kretzschmar E, Kuroda K, Garten W, Schmidt MF, Klenk HD, Rott R.
    J Virol; 1991 May 29; 65(5):2491-500. PubMed ID: 1901916
    [Abstract] [Full Text] [Related]

  • 17. A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range.
    Dong J, Roth MG, Hunter E.
    J Virol; 1992 Dec 29; 66(12):7374-82. PubMed ID: 1331528
    [Abstract] [Full Text] [Related]

  • 18. Role of the Glu residues of the influenza hemagglutinin fusion peptide in the pH dependence of fusion activity.
    Korte T, Epand RF, Epand RM, Blumenthal R.
    Virology; 2001 Oct 25; 289(2):353-61. PubMed ID: 11689057
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
    Staschke KA, Hatch SD, Tang JC, Hornback WJ, Munroe JE, Colacino JM, Muesing MA.
    Virology; 1998 Sep 01; 248(2):264-74. PubMed ID: 9721235
    [Abstract] [Full Text] [Related]

  • 20. Variant influenza virus hemagglutinin that induces fusion at elevated pH.
    Doms RW, Gething MJ, Henneberry J, White J, Helenius A.
    J Virol; 1986 Feb 01; 57(2):603-13. PubMed ID: 3003392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.